Letter to the Editor
Sir: We appreciate the comments by Stip and colleagues andwould like to respond to several issues they have raised.
They suggest that the notion of D2 occupancy thresholds forclinical response and extrapyramidal symptoms (EPS) (approximately60% and 80%, respectively) does not adequatelyaccount for that group of individuals who require higher antipsychoticdoses than what this model might predict. This is true.Certain individuals, albeit a small subgroup, appear to benefitfrom high-dose therapy, reminding us that existing theories arenot absolute.
Save
Cite
Advertisement
GAM ID: sidebar-top